HYPD
Price
$3.84
Change
-$0.18 (-4.48%)
Updated
Dec 26 closing price
Capitalization
31.38M
Intraday BUY SELL Signals
INKT
Price
$11.95
Change
+$0.05 (+0.42%)
Updated
Dec 26 closing price
Capitalization
56.1M
Intraday BUY SELL Signals
Interact to see
Advertisement

HYPD vs INKT

Header iconHYPD vs INKT Comparison
Open Charts HYPD vs INKTBanner chart's image
Hyperion DeFi
Price$3.84
Change-$0.18 (-4.48%)
Volume$138.38K
Capitalization31.38M
MiNK Therapeutics
Price$11.95
Change+$0.05 (+0.42%)
Volume$7.43K
Capitalization56.1M
HYPD vs INKT Comparison Chart in %
HYPD
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HYPD vs. INKT commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPD is a Hold and INKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (HYPD: $3.84 vs. INKT: $11.95)
Brand notoriety: HYPD and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HYPD: 38% vs. INKT: 36%
Market capitalization -- HYPD: $31.38M vs. INKT: $56.1M
HYPD [@Biotechnology] is valued at $31.38M. INKT’s [@Biotechnology] market capitalization is $56.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPD’s FA Score shows that 1 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • HYPD’s FA Score: 1 green, 4 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both HYPD and INKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPD’s TA Score shows that 5 TA indicator(s) are bullish while INKT’s TA Score has 4 bullish TA indicator(s).

  • HYPD’s TA Score: 5 bullish, 4 bearish.
  • INKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HYPD is a better buy in the short-term than INKT.

Price Growth

HYPD (@Biotechnology) experienced а +4.63% price change this week, while INKT (@Biotechnology) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($56.1M) has a higher market cap than HYPD($31.4M). HYPD YTD gains are higher at: 2530.137 vs. INKT (71.474). INKT has higher annual earnings (EBITDA): -11.23M vs. HYPD (-23.34M). INKT has more cash in the bank: 14.3M vs. HYPD (8.22M). INKT has less debt than HYPD: INKT (5.73M) vs HYPD (8.49M). HYPD has higher revenues than INKT: HYPD (345K) vs INKT (0).
HYPDINKTHYPD / INKT
Capitalization31.4M56.1M56%
EBITDA-23.34M-11.23M208%
Gain YTD2530.13771.4743,540%
P/E RatioN/AN/A-
Revenue345K0-
Total Cash8.22M14.3M58%
Total Debt8.49M5.73M148%
FUNDAMENTALS RATINGS
HYPD: Fundamental Ratings
HYPD
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HYPDINKT
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HYPD
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NLST0.87N/A
+0.46%
Netlist, Inc.
GNRV3.81N/A
N/A
Grand River Commerce Inc.
ITGGF10.80N/A
N/A
TG Holding SPA
AILLO69.50N/A
N/A
Ameren Illinois Company
NINTF2.59N/A
N/A
NINETY ONE PLC

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with QNTM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then QNTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
-4.48%
QNTM - HYPD
42%
Loosely correlated
-4.49%
INKT - HYPD
34%
Loosely correlated
+0.42%
CTXR - HYPD
32%
Poorly correlated
+5.02%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
28%
Poorly correlated
-7.80%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
+0.42%
RAIN - INKT
43%
Loosely correlated
-8.43%
PHVS - INKT
34%
Loosely correlated
-0.66%
HYPD - INKT
34%
Loosely correlated
-4.48%
TERN - INKT
30%
Poorly correlated
-2.03%
ORMP - INKT
29%
Poorly correlated
-6.35%
More